Galectin Therapeutic (GALT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2005 | 12-2004 | 12-2003 | 12-2002 | 12-2001 | |
| Operating Expenses | 6,650 | 7,300 | 4,930 | 3,280 | 3,410 |
| Operating Income | -6,650 | -7,300 | -4,930 | -3,280 | -3,410 |
| Interest Expense | 0 | 0 | 4 | 410 | 60 |
| Other Income | 110 | 120 | 64 | 20 | -500 |
| Pre-tax Income | -6,540 | -7,180 | -4,870 | -3,670 | -3,970 |
| Net Income Continuous | -6,544 | -7,180 | -4,873 | -3,678 | -3,970 |
| Net Income | $-6,540 | $-7,180 | $-4,870 | $-3,670 | $-3,970 |
| EPS Basic Total Ops | -1.44 | -1.68 | -1.38 | -1.32 | N/A |
| EPS Basic Continuous Ops | -1.44 | -1.67 | -1.37 | -1.35 | N/A |
| EPS Diluted Total Ops | -1.44 | -1.68 | -1.38 | -1.32 | N/A |
| EPS Diluted Continuous Ops | -1.44 | -1.67 | -1.37 | -1.35 | N/A |
| EBITDA(a) | $-6,570 | $-7,220 | $-4,850 | $-3,070 | $-2,010 |